ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
-0,01%
Bitcoin
63.541,89
1,04%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. AMEX
  6. Mast Therapeutics, Inc. (ANX)

  7. Mast Therapeutics, Inc. (ANX) News

ANX

Adventrx (ANX)

Mast Therapeutics, Inc.
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:ANX
DatumZeitQuelleÜberschriftSymbolFirma
27/04/201509h21Analyst Ratings NetworkRoth Capital Initiates Coverage on Mast Therapeutics (ANX)AMEX:ANXMast Therapeutics, Inc.
16/06/201414h00PR Newswire (US)Mast Therapeutics Initiates Sub-Study Within Phase 3 EPIC TrialAMEX:ANXMast Therapeutics, Inc.
14/04/201414h00PR Newswire (US)Mast Therapeutics Announces New Data Supporting MST-188 In Sickle Cell DiseaseAMEX:ANXMast Therapeutics, Inc.
10/02/201414h00PR Newswire (US)Mast Therapeutics Signs Definitive Agreement To Acquire Aires Pharmaceuticals, Inc.AMEX:ANXMast Therapeutics, Inc.
03/09/201314h00PR Newswire (US)Mast Therapeutics To Present At The Rodman & Renshaw 15th Annual Healthcare Conference On September 10AMEX:ANXMast Therapeutics, Inc.
11/03/201313h00PR Newswire (US)ADVENTRX Completes Name Change To "Mast Therapeutics, Inc."; New Ticker Symbol: "MSTX"AMEX:ANXMast Therapeutics, Inc.
01/03/201322h11Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANXMast Therapeutics, Inc.
28/02/201323h15PR Newswire (US)ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX"AMEX:ANXMast Therapeutics, Inc.
28/02/201322h01PR Newswire (US)Adventrx To Develop ANX-188 For Complications Of Arterial DiseaseAMEX:ANXMast Therapeutics, Inc.
26/02/201322h38Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANXMast Therapeutics, Inc.
26/02/201314h00PR Newswire (US)ADVENTRX Reviews Data Supporting Development Of ANX-188 In New IndicationsAMEX:ANXMast Therapeutics, Inc.
25/02/201314h00PR Newswire (US)ADVENTRX To Present At The Cowen And Company 33rd Annual Health Care Conference On March 4AMEX:ANXMast Therapeutics, Inc.
11/02/201314h00PR Newswire (US)ADVENTRX Initiates Thorough QT/QTc Clinical Study Of ANX-188AMEX:ANXMast Therapeutics, Inc.
08/02/201323h27Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANXMast Therapeutics, Inc.
05/02/201314h00PR Newswire (US)ADVENTRX To Present At The 15th Annual BIO CEO & Investor Conference On February 12AMEX:ANXMast Therapeutics, Inc.
30/01/201313h00PR Newswire (US)ADVENTRX Initiates Pivotal Phase 3 Study of ANX-188AMEX:ANXMast Therapeutics, Inc.
19/01/201300h24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
10/01/201315h55Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)AMEX:ANXMast Therapeutics, Inc.
10/01/201315h55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:ANXMast Therapeutics, Inc.
04/01/201314h00PR Newswire (US)ADVENTRX Announces Appointment of Chief Financial OfficerAMEX:ANXMast Therapeutics, Inc.
03/01/201322h45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
03/01/201322h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
03/01/201322h42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
03/01/201322h40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
03/01/201322h40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ANXMast Therapeutics, Inc.
03/01/201312h07Edgar (US Regulatory)Current report filing (8-K)AMEX:ANXMast Therapeutics, Inc.
03/01/201312h07Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANXMast Therapeutics, Inc.
02/01/201314h00PR Newswire (US)ADVENTRX To Present At The 6th Annual OneMedForum Emerging Company Finance Conference On January 8AMEX:ANXMast Therapeutics, Inc.
19/12/201222h19Edgar (US Regulatory)Other Filing (40-app/a)AMEX:ANXMast Therapeutics, Inc.
19/12/201222h18Edgar (US Regulatory)Current Report Filing (8-k)AMEX:ANXMast Therapeutics, Inc.
 Showing the most relevant articles for your search:AMEX:ANX

Kürzlich von Ihnen besucht

USOTC
ADDYY
Adidas (QX)
TG
D7G
Nel ASA
NASDAQ
NVDA
NVIDIA
CCOM
US30
US 30
NYSE
DIS
Walt Disney
USOTC
BNPQY
BNP Paribas (QX)
DBI
DAX
DAX
CCOM
US100
US Tech 100
FX
EURUSD
Euro vs US Dollar
AMEX
XLF
Financial Select Sector
USOTC
BASFY
BASF (QX)
TG
432
Arbor Metals
NASDAQ
MSFT
Microsoft
TG
RHM
Rheinmetall
CCOM
SILVER
SILVER
TG
TUI1
Tui
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten